Get started
Author

Renate Panzer‐Grümayer

Observed names: R Panzer-Grümayer, R. Panzer-Gruemayer, R. Panzer-Grumayer, R. Panzer-Grümayer, RE Panzer-Grumayer, Renate E Panzer-Grümayer, Renate E Panzer-Grümayer, Renate Panzer-Grumayer, Renate Panzer-Grümayer, Renate Panzer-Grümayer
Observed institutions: Innsbruck Medical University, Radboud University Nijmegen, University of Freiburg, Medical University of Silesia, Universität Innsbruck, Universität Ulm, Justus-Liebig-Universität Gießen, University of Zurich, Heidelberg University, University of Würzburg, Ghent University Hospital, University Medical Center Freiburg, Radboud University Medical Center, Christian-Albrechts-Universität zu Kiel, Medizinische Hochschule Hannover, Humboldt-Universität zu Berlin, Jazz Pharmaceuticals (United States), University Medical Center Hamburg-Eppendorf, University Hospital Schleswig-Holstein, St Anna Children's Hospital, University Hospital Frankfurt, Erasmus MC - Sophia Children’s Hospital, St. Anna Children's Cancer Research Institute, Heinrich Heine University Düsseldorf, Medical University of Vienna, Friedrich Schiller University Jena, Charité – Universitätsmedizin Berlin
OpenAlex ID: A5113799249
Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study
2010 · Valentino Conter, Claus R. Bartram, et al. · Blood · 785
PDF
The MLL recombinome of acute leukemias in 2017
2017 · C Meyer, T Burmeister, et al. · Leukemia · 725
PDF
The MLL recombinome of acute leukemias in 2013
2013 · C Meyer, J Hofmann, et al. · Leukemia · 507
PDF
Late MRD response determines relapse risk overall and in subsets of childhood T-cell ALL: results of the AIEOP-BFM-ALL 2000 study
2011 · Martin Schrappe, Maria Grazia Valsecchi, et al. · Blood · 440
New insights to the MLL recombinome of acute leukemias
2009 · C Meyer, E Kowarz, et al. · Leukemia · 413
Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemia
2008 · T Flohr, A Schrauder, et al. · Leukemia · 361
IKZF1 plus Defines a New Minimal Residual Disease–Dependent Very-Poor Prognostic Profile in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia
2018 · Martin Stanulla, Elif Dagdan, et al. · Journal of Clinical Oncology · 315
PDF
Characterization of Rare, Dormant, and Therapy-Resistant Cells in Acute Lymphoblastic Leukemia
2016 · Sarah Ebinger, Erbey Ziya Özdemir, et al. · Cancer Cell · 279
PDF
Genomics and drug profiling of fatal TCF3-HLF−positive acute lymphoblastic leukemia identifies recurrent mutation patterns and therapeutic options
2015 · Ute Fischer, Michael Forster, et al. · Nature Genetics · 267
Acute lymphoblastic leukemia in children with Down syndrome: a retrospective analysis from the Ponte di Legno study group
2013 · Trudy D. Buitenkamp, Shai Izraeli, et al. · Blood · 257
PDF
Use of Allogeneic Hematopoietic Stem-Cell Transplantation Based on Minimal Residual Disease Response Improves Outcomes for Children With Relapsed Acute Lymphoblastic Leukemia in the Intermediate-Risk Group
2013 · Cornelia Eckert, Günter Henze, et al. · Journal of Clinical Oncology · 171
KRAS and CREBBP mutations: a relapse-linked malicious liaison in childhood high hyperdiploid acute lymphoblastic leukemia
2015 · K Malinowska-Ozdowy, C Frech, et al. · Leukemia · 128
PDF
Immunobiological diversity in infant acute lymphoblastic leukemia is related to the occurrence and type of MLL gene rearrangement
2007 · M W J C Jansen, L Corral, et al. · Leukemia · 118
Glucocorticoid-regulated microRNAs and mirtrons in acute lymphoblastic leukemia
2009 · J Rainer, C Ploner, et al. · Leukemia · 117
Time point-dependent concordance of flow cytometry and real-time quantitative polymerase chain reaction for minimal residual disease detection in childhood acute lymphoblastic leukemia
2012 · G. Gaipa, G. Cazzaniga, et al. · Haematologica · 113
PDF
ETV6/RUNX1-positive relapses evolve from an ancestral clone and frequently acquire deletions of genes implicated in glucocorticoid signaling
2011 · Lilian Kuster, Reinhard Grausenburger, et al. · Blood · 111
Minimal Residual Disease Values Discriminate Between Low and High Relapse Risk in Children With B-Cell Precursor Acute Lymphoblastic Leukemia and an Intrachromosomal Amplification of Chromosome 21: The Austrian and German Acute Lymphoblastic Leukemia Berlin-Frankfurt-Münster (ALL-BFM) Trials
2008 · Andishe Attarbaschi, Georg Mann, et al. · Journal of Clinical Oncology · 111
PDF
CREBBP HAT domain mutations prevail in relapse cases of high hyperdiploid childhood acute lymphoblastic leukemia
2012 · A Inthal, P Zeitlhofer, et al. · Leukemia · 107
Reduced-Intensity Delayed Intensification in Standard-Risk Pediatric Acute Lymphoblastic Leukemia Defined by Undetectable Minimal Residual Disease: Results of an International Randomized Trial (AIEOP-BFM ALL 2000)
2017 · Martin Schrappe, Kirsten Bleckmann, et al. · Journal of Clinical Oncology · 98
PDF
TEL-AML1 regulation of survivin and apoptosis via miRNA-494 and miRNA-320a
2010 · Christofer Diakos, Sheng Zhong, et al. · Blood · 72
PDF
Monitoring minimal residual disease in children with high-risk relapses of acute lymphoblastic leukemia: prognostic relevance of early and late assessment
2015 · C Eckert, N Hagedorn, et al. · Leukemia · 71
CD371 cell surface expression: a unique feature of DUX4 -rearranged acute lymphoblastic leukemia
2019 · Dagmar Schinnerl, Ester Mejstrikova, et al. · Haematologica · 70
PDF
TEL Deletion Analysis Supports a Novel View of Relapse in Childhood Acute Lymphoblastic Leukemia
2004 · Jan Zuna, Anthony M. Ford, et al. · Clinical Cancer Research · 70
PDF
Late Recurrence of Childhood T-Cell Acute Lymphoblastic Leukemia Frequently Represents a Second Leukemia Rather Than a Relapse: First Evidence for Genetic Predisposition
2011 · Tomasz Szczepański, Vincent H.J. van der Velden, et al. · Journal of Clinical Oncology · 67
PDF
A novel translocation, t(14;19)(q32;p13), involving IGH@ and the cytokine receptor for erythropoietin
2008 · L J Russell, D G De Castro, et al. · Leukemia · 66
Works count: 86
Citation count: 6,814
H-index: 36
I10-index: 57
Year
Topic
Type